Jonathan Smith, Author at Labiotech.eu

About

Reporter for Labiotech. I hail from the UK. I was born in Bristol, studied Neuroscience in the University of Bristol, and trained mice in Eisai, Hertfordshire, for one year. I then tickled locusts for my Ph.D. at the University of Leicester, before eventually ending up here!
Out of the office, I travel, play video games and board games, drink beer and play the piano.

Articles by Jonathan Smith

Best in Biotech 16 Nov 2022

Six biotech stocks trading below cash right now

The biotech stock market is currently in a tough spot, with many companies facing suppressed valuations. We’ve listed six public companies trading with a market cap below their cash in…

November 16, 2022 - 6 minutesmins - By Jonathan Smith

Startup Scout 15 Nov 2022

Nagi Bioscience tests drugs on worms using microfluidics

The Swiss startup Nagi Bioscience aims to speed up drug and chemical safety testing by automating research on a worm called Caenorhabditis elegans. For companies developing a drug or chemical…

November 15, 2022 - 5 minutesmins - By Jonathan Smith

Interview 14 Nov 2022

MaaT Pharma: leading the charge in microbiome therapeutics

The first generation of microbiome therapeutics is hitting its first approvals. Savita Bernal, chief business officer at the French biotech MaaT Pharma outlines the firm’s efforts to blaze a trail…

November 14, 2022 - 5 minutesmins - By Jonathan Smith

Startup Scout 10 Nov 2022

ResQ Biotech is using bacteria to discover Alzheimer’s treatments

Protein misfolding underlies many incurable conditions such as Alzheimer’s disease and amyotrophic lateral sclerosis (ALS). The Greek startup ResQ Biotech is harnessing bacteria to test potential peptide treatments for these…

November 10, 2022 - 4 minutesmins - By Jonathan Smith

Best in Biotech 10 Nov 2022

The five hottest biotech startup companies in Brazil

Brazil’s developing economy is supporting an emerging biotech startup scene. Catch a glimpse of the biotech companies causing a stir in Brazil. Over the decades, Brazil has grown into an…

November 10, 2022 - 4 minutesmins - By Jonathan Smith

Interview 7 Nov 2022

AI could tackle pharmaceutical manufacturing bottlenecks

Artificial intelligence (AI) is making waves in the world of drug discovery. Rajiv Anand, founder and CEO of the firm Quartic.ai, explains how the tool could also make pharmaceutical manufacturing…

November 7, 2022 - 6 minutesmins - By Jonathan Smith

In Depth 3 Nov 2022

What’s on the horizon for gene editing-based therapies?

Gene editing has come far in the past decade. However, the field is still finding its feet regarding challenges such as drug delivery, regulation and competition with first-generation gene therapies. …

November 3, 2022 - 8 minutesmins - By Jonathan Smith

Startup Scout 2 Nov 2022

Breakpoint Therapeutics sabotages DNA repair in cancer cells

The Hamburg-based Evotec spinout Breakpoint Therapeutics is working on cancer treatments that block the ability of tumor cells to repair their own DNA. In the last decade, a new class…

November 2, 2022 - 4 minutesmins - By Jonathan Smith

Anastasiia Slynko biotech investment october 2022

In Depth 1 Nov 2022

The biggest private biotech investments in October 2022

The companies Tempus Labs, Oculis and VectorBuilder Biotechnology bagged the biggest biotech investments in October 2022. Oncology and biomanufacturing research attracted the biggest funding rounds. We’re heading for the beginning…

November 1, 2022 - 3 minutesmins - By Jonathan Smith

longevity treatment bioAge Kristen Fortney

Interview 31 Oct 2022

AI and biobanks could open the way to longevity treatments

The development of longevity treatments is hampered by a lack of biomarkers and validated drug targets. BioAge’s co-founder and CEO, Kristen Fortney, explains how the firm is enlisting machine learning…

October 31, 2022 - 7 minutesmins - By Jonathan Smith

Persephone Bisociences Microbiome health

Startup Scout 28 Oct 2022

Persephone Biosciences studies the microbiome in baby poop

Disruption in the gut microbiome is linked to a wide range of health problems in newborn babies and patients with cancer. Persephone Biosciences is studying stool samples from these populations…

October 28, 2022 - 6 minutesmins - By Jonathan Smith

News and Trends 26 Oct 2022

Singapore approves gas fermentation-powered protein

A food ingredient developed by the Finnish startup Solar Foods has earned its first market approval in Singapore. The product is brewed using microorganisms fed with carbon dioxide and electricity…

October 26, 2022 - 3 minutesmins - By Jonathan Smith

In Depth 20 Oct 2022

Opportunities and challenges for cell and gene therapy investments

Companies in the cell and gene therapy space are struggling to raise investments amid adverse market conditions. However, this could be an opportunity for the strongest companies and investors to…

October 20, 2022 - 9 minutesmins - By Jonathan Smith

Anastasiia Slynko neobe therapeutics cancer

Startup Scout 19 Oct 2022

Neobe Therapeutics breaks down tumor defenses with bacteria

Many cancer patients cannot benefit from cancer immunotherapy because their tumors are protected from the immune system. Neobe Therapeutics’ bacterial therapy is designed to strip the tumors of their protective…

October 19, 2022 - 4 minutesmins - By Jonathan Smith

Best in Biotech 18 Oct 2022

The hottest private biotech companies in Australia

Australia has a strong base in biotechnology, with many incentives for R&D and commercialization. Here are the top five private Australian biotech companies that have recently showcased the country’s credentials…

October 18, 2022 - 5 minutesmins - By Jonathan Smith

In Depth 17 Oct 2022

UK grants that can give biotech startups a vital jump-start

Grants are a vital lifeline that help biotech startups get off the ground, especially for underrepresented entrepreneurs. The Women in Synthetic Biology (WiSB) network recently gave detailed advice for helping…

October 17, 2022 - 7 minutesmins - By Jonathan Smith

Caszyme crispr climate change Anastasiia Slynko

Interview 17 Oct 2022

CRISPR gene editing: a key tool for counteracting climate change

Monika Paulė, CEO and co-founder of the Lithuanian CRISPR developer Caszyme, explains how gene editing technology could fight climate change by boosting agriculture and biodiversity. The invention of CRISPR-Cas gene…

October 17, 2022 - 6 minutesmins - By Jonathan Smith

boston bioworks precision fermentation Elena Resko

Startup Scout 13 Oct 2022

Boston Bioworks helps precision fermentation startups scale up

Precision fermentation startups have few options when looking for ways to scale up their technology. The newly launched scaling service provider Boston Bioworks aims to address this bottleneck. In the…

October 13, 2022 - 5 minutesmins - By Jonathan Smith

Mike Nally Generate Biomedicines ai drug discovery

Interview 12 Oct 2022

Boosting pharma’s falling productivity with AI in drug discovery

The pharmaceutical industry is struggling with mounting costs of drug development. Generate Biomedicines’ CEO, Michael Nally, outlines the firm’s mission to tackle the trend by making drug discovery scalable. Over…

October 12, 2022 - 5 minutesmins - By Jonathan Smith

Anastasiia Slynko biotech investment 744x368 1

In Depth 11 Oct 2022

The biggest private biotech investments in September 2022

The companies Acelyrin, InnovaFeed and Arsenal Biosciences bagged the biggest biotech investments in September 2022, with insect protein and cell therapies attracting big funding rounds. Autumn is in full swing…

October 11, 2022 - 3 minutesmins - By Jonathan Smith

Beyond Biotech - the podcast from Labiotech

View More

Newsletter Signup - Sidebar

"*" indicates required fields

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

Register for the Webinar

View all companies A-Z

Find new scientific partnerships. Create a free IN-PART account

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Subcribe to our newsletter

Learn more about Inova, the leading platform for biopharma partnering